# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5130156 | A | Inhibition of human CYP11B2 expressed in Chinese hamster V79 MZh cells using [14C]-deoxycorticosteron as substrate measured after 6 hrs by phosphoimager analysis | Homo sapiens | 37 | cell-based format | Scientific Literature | ||
2. | ALA5130157 | A | Selectivity ratio of IC50 for inhibition of human CYP11B2 to IC50 for inhibition of human CYP11B1 | Homo sapiens | 37 | assay format | Scientific Literature | ||
3. | ALA5130158 | A | Inhibition of human placental microsome CYP19 using [1beta-3H]-androstenedione as substrate | Homo sapiens | 1 | microsome format | Scientific Literature | ||
4. | ALA5130159 | A | Inhibition of human CYP11B1 expressed in Chinese hamster V79 MZh cells using [14C]-deoxycorticosteron as substrate measured after 6 hrs by phosphoimager analysis | Homo sapiens | 37 | cell-based format | Scientific Literature | ||
5. | ALA5130160 | A | Inhibition of human CYP17 expressed in Escherichia coli | Homo sapiens | 1 | assay format | Scientific Literature | ||
6. | ALA5130161 | A | Inhibition of human hepatic recombinant CYP1A2 using cocktail of substrate by LC-MS/MS analysis | Homo sapiens | 1 | single protein format | Scientific Literature | ||
7. | ALA5130162 | A | Inhibition of human hepatic recombinant CYP2C9 using cocktail of substrate by LC-MS/MS analysis | Homo sapiens | 1 | single protein format | Scientific Literature | ||
8. | ALA5130163 | A | Inhibition of human hepatic recombinant CYP2C19 using cocktail of substrate by LC-MS/MS analysis | Homo sapiens | 1 | single protein format | Scientific Literature | ||
9. | ALA5130164 | A | Inhibition of human hepatic recombinant CYP2D6 using cocktail of substrate by LC-MS/MS analysis | Homo sapiens | 1 | single protein format | Scientific Literature | ||
10. | ALA5130165 | A | Inhibition of human hepatic recombinant CYP3A using cocktail of substrate by LC-MS/MS analysis | Homo sapiens | 1 | single protein format | Scientific Literature | ||
11. | ALA5130166 | P | Aqueous solubility of compound | 1 | small-molecule physicochemical format | Scientific Literature | |||
12. | ALA5130167 | T | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA5130168 | T | Cytotoxicity against Chinese hamster V79 cells assessed as reduction in cell viability | Cricetulus griseus | 1 | cell-based format | Scientific Literature | ||
14. | ALA5130169 | A | Cmax in Sprague-Dawley rat at 5 mg/kg, iv measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
15. | ALA5130170 | A | Cmax in Sprague-Dawley rat at 25 mg/kg, po measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
16. | ALA5130171 | A | Tmax in Sprague-Dawley rat at 5 mg/kg, iv measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
17. | ALA5130172 | A | Tmax in Sprague-Dawley rat at 25 mg/kg, po measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
18. | ALA5130173 | A | AUC (0 to infinity) in Sprague-Dawley rat at 5 mg/kg, iv measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
19. | ALA5130174 | A | AUC (0 to infinity) in Sprague-Dawley rat at 25 mg/kg, po measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
20. | ALA5130175 | A | Terminal half life in Sprague-Dawley rat at 5 mg/kg, iv measured up to 24 hrs by LC-MS analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature |